BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
Cambrex to Announce Third Quarter 2012 Financial Results on October 31, 2012
Posted on October 26, 2012 at 08:07 AM EDT

EAST RUTHERFORD, N.J., Oct. 26, 2012 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM) announced that third quarter 2012 financial results will be released on Wednesday, October 31, 2012 after the market closes.

The Company will host a conference call to discuss the financial results.

   Third Quarter 2012 Earnings Conference Call


When:  

Thursday, November 1, 2012 at 8:30 a.m. Eastern Time



Dial-in:  

1-888-430-8705 for U.S.


1-719-325-2455 for International


Passcode:  1704787



Dial-in Replay:

1-888-203-1112 for U.S.


1-719-457-0820 for International


Passcode: 1704787


Available through Thursday, November 8, 2012



Webcast:

www.cambrex.com   

About Cambrex

Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  We offer Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Our development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products.  For more information, please visit www.cambrex.com.  

SOURCE Cambrex Corporation

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here